对食中针对帕金森病关键基因和途径的植物化学物质的洞察:一个网络药理学方法

相关实验视频

Updated: Jul 1, 2025

08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.5K

Devi Soorya Narayana Sasikumar¹, Premkumar Thiruselvam¹, Vino Sundararajan¹

¹Integrative Multiomics Lab, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, TN, 632014, India.

Computers in biology and medicine

|March 9, 2024

概括

饮食化合物如白卡莱因和药物拉萨吉林在帕金森病 (PD) 管理方面表现有前途,因为它们准了神经退行相关的关键蛋白质. 这项研究使用了网络药理学来识别这些潜在的治疗方法并了解它们的机制.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
计算生物学计算生物学

背景情况:

帕金森病 (PD) 涉及多巴胺基神经元退化,氧化应激在亡中起着关键作用.
饮食中的植物化学物质正因其提高PD神经元存活率的潜力而受到关注.
需要一个全面的网络药理学方法来理解这些化合物的机制.

研究的目的:

研究饮食中的植物化学物质和用于帕金森病管理的批准药物的作用机制.
通过网络药理学方法识别PD的潜在治疗剂.
揭开PD治疗中涉及的分子标和途径.

主要方法:

在文献中搜索配体 (植物化学品,PD药物) 并从STITCH数据库中提取相关的目标.
基因-基因相互作用 (GGI) 和带-标相互作用 (LTI) 网络的构建和分析.
生物信息分析包括枢纽基因识别,途径丰富,转录因子/miRNA分析,分子对接和分子动力学模拟.

主要成果:

确定了69个配体和144个独特的目标,其中EP300,MAPK1和CREBBP是关键的枢纽基因.
关键的途径和基因本体学术语包括神经退行,MAPK信号传递,亡和结合.
拜卡莱因和拉萨吉林被确定为有前途的干,向MAPK1,形成稳定的复合体.

结论:

拜卡莱因和拉萨吉林显示出作为帕金森病管理的临床前候选者的潜力.
这项研究强调了网络药理学在确定神经退行性疾病的新疗法策略中的有效性.
了解分子相互作用为PD的进一步药物开发提供了基础.

关键词:

在 Baicalein 的酒吧里这就是CREBBP.多巴氨基神经元是多巴氨基神经元.EP300 EP300 在线播放在ERK2的基础上.在MAPK1中,MAPK1是MAPK1.模拟MDMD的模拟网络药理学网络药理学帕金森病的疾病.拉萨吉林素是一种

相关概念视频

01:24

Parkinson's Disease: Treatment

268

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

268

01:15

Parkinson's Disease: Overview

544

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

544

02:26

Protein Networks

3.9K

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...

3.9K

01:37

Neural Regulation

39.4K

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

39.4K

01:29

Drugs Affecting Neurotransmitter Synthesis

1.4K

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...

1.4K

01:19

Interactions Between Signaling Pathways

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...